Day: August 27, 2024

NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the full year ended June 30, 2024. The webcast will begin at 6.30pm EDT, Wednesday, August 28; 8.30am AEST, Thursday, August 29, 2024. It can be accessed via: https://webcast.openbriefing.com/msb-fyr-2024/ The archived webcast will be available on the Investor page of the Company’s website: www.mesoblast.com About Mesoblast Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to...

MELBOURNE, Australia, Aug. 28, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-CDx, (Pixclara™1, 18F-floretyrosine or 18F-FET), an investigational PET2 agent for the characterization of progressive or recurrent glioma (brain cancer) from treatment related changes in both adult and pediatric patients. Given the potential to address significant unmet medical need, Pixclara™1 has been granted Orphan Drug3 and Fast Track4 designation by the FDA, which facilitates expedited review and closer consultation with the agency during the review process. FET PET (Pixclara™1) is already included in international clinical practice guidelines for the imaging...

Reduces debt and accelerates high-impact well and facility optimization program CALGARY, Alberta, Aug. 27, 2024 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) is pleased to announce that it is offering rights (the “Rights Offering”) to eligible holders of its common shares (the “Common Shares”) of record at the close of business on September 9, 2024 (the “Record Date”). Pursuant to the Rights Offering, each holder of Common Shares resident in a province or territory in Canada (the “Eligible Jurisdictions”) will receive one right (a “Right”) for each one Common Share held. Each Right will entitle the holder to subscribe for 0.71286 of a Common Share (the “Basic Subscription Privilege”). As a result, holders of Common Shares may exercise 1.4028 Rights and pay $0.2448 per share (the “Subscription...

LEADING EDGE MATERIALS ANNOUNCES UPDATE ON PRIVATE PLACEMENT NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN LEADING EDGE MATERIALS IN ANY JURISDICTION. Vancouver, August 27, 2024 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces that further to its news release of July 15, 2024 regarding the plans to complete a private placement, TSX Venture Exchange has granted the Company a 30 day extension to close the private...

Perth, Aug. 28, 2024 (GLOBE NEWSWIRE) — Perth, Western Australia/August 28, 2024/African focused gold producer Perseus Mining Limited (ASX/TSX: PRU), has released its Annual Report for the financial year ending June 30, 2024 (FY24), which includes Perseus’s Annual Financial Report, and its Sustainable Development Report. highlights financial performanceRevenue of US$1.0261 billion (up 7%)2, Earnings before interest, tax, depreciation and amortisation (EBITDA) of US$625.2 million (up 13%)2 and Profit after tax of US$364.8 million (up 14%)2Basic earnings per share of US$0.236 cents per share (up 12%)2 resulting in an earnings yield of 13.3% and a price: earnings (P/E) ratio of 7.54Net cash flow from operating activities of US$429.2 million (up 1%)2 or US$0.3133 cents per share resulting in a price: operating cashflow (P/OCF)...

GUADALAJARA, Mexico, Aug. 27, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) that it has concluded the ordinary review process for the Master Development Program (“MDP”) and Maximum Tariffs for its airports in Mexico, approved by the Ministry of Infrastructure, Communications and Transportation (Secretaría de Infraestructura, Comunicaciones y Transportes “SICT”), through the Federal Civil Aviation Agency (Agencia Federal de Aviación Civil “AFAC”) for the 2025-2029 period. The maximum tariffs per workload unit for each airport were determined by the AFAC, based on projections for traffic, operating costs, and capital investments included in the Master Development Program, as well as the Reference Values and discount rate, following the parameters established...

VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) — Versus Systems, Inc. (NASDAQ: VS) (the “Company”) announces that it has received a letter from the listing qualifications department staff of the NASDAQ Stock Market (“NASDAQ”), notifying the Company that the stockholders’ equity of $1,797,764 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024 was below the minimum stockholders’ equity of $2,500,000. The minimum stockholders’ equity of $2,500,000 is required for continued listing on the NASDAQ Capital Market as set forth in NASDAQ listing rule 5550(b)(1), and the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. The Company has been provided until October 7, 2024, to submit a plan to regain compliance with the...